SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Phibro Animal Health Corporation (PAHC) trades at a trailing P/E of 25.7, forward P/E of 19.5. Trailing earnings yield is 3.90%, forward earnings yield 5.13%. PEG 0.01 (Peter Lynch undervalued ≤1.0). Graham Number is $20.47.
Criteria proven by this page:
- VALUE (49/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 19.5 (down from trailing 25.7) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.01 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 3.90% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 5.13% as earnings recover.
- Analyst consensus target $49.00 (-17% downside) — analysts see meaningful downside risk at the current price level.
Overall SharesGrow Score: 56/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
49/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — PAHC
Valuation Multiples
P/E (TTM)25.7
Forward P/E19.5
PEG Ratio0.01
Forward PEG0.13
P/B Ratio7.11
P/S Ratio1.61
EV/EBITDA13.6
Per Share Data
EPS (TTM)$2.27
Forward EPS (Est.)$3.03
Book Value / Share$8.20
Revenue / Share$36.13
FCF / Share$1.17
Yields & Fair Value
Earnings Yield3.90%
Forward Earnings Yield5.13%
Dividend Yield0.82%
Graham Number$20.47
SharesGrow IV$216.72 (+267.2%)
Analyst Target$49.00 (-17%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
8.9 |
0.25 |
8.10 |
0.98 |
2.14% |
| 2017 |
22.7 |
-1.00 |
9.68 |
1.91 |
1.08% |
| 2018 |
28.5 |
-23.25 |
10.01 |
2.26 |
0.87% |
| 2019 |
23.4 |
-1.45 |
5.92 |
1.54 |
1.45% |
| 2020 |
31.7 |
-0.82 |
5.65 |
1.33 |
1.83% |
| 2021 |
21.5 |
0.35 |
4.90 |
1.40 |
1.66% |
| 2022 |
15.8 |
-1.62 |
2.95 |
0.82 |
2.51% |
| 2023 |
17.0 |
-0.51 |
1.96 |
0.57 |
3.50% |
| 2024 |
285.7 |
-3.09 |
2.69 |
0.68 |
2.82% |
| 2025 |
21.4 |
0.01 |
3.62 |
0.80 |
1.88% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$2.07 |
$751.5M |
$82.7M |
11% |
| 2017 |
$1.61 |
$764.3M |
$64.6M |
8.5% |
| 2018 |
$1.61 |
$820M |
$64.9M |
7.9% |
| 2019 |
$1.35 |
$828M |
$54.7M |
6.6% |
| 2020 |
$0.83 |
$800.4M |
$33.55M |
4.2% |
| 2021 |
$1.34 |
$833.35M |
$54.39M |
6.5% |
| 2022 |
$1.21 |
$942.3M |
$49.18M |
5.2% |
| 2023 |
$0.81 |
$977.89M |
$32.61M |
3.3% |
| 2024 |
$0.06 |
$1.02B |
$2.42M |
0.2% |
| 2025 |
$1.19 |
$1.3B |
$48.26M |
3.7% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$3.03 |
$2.98 – $3.07 |
$1.49B |
$1.48B – $1.51B |
3 |
| 2027 |
$3.37 |
$3.13 – $3.54 |
$1.54B |
$1.53B – $1.55B |
3 |
| 2028 |
$3.71 |
$3.68 – $3.74 |
$1.59B |
$1.59B – $1.59B |
1 |
